Page last updated: 2024-08-24

brequinar and Genital Neoplasms, Female

brequinar has been researched along with Genital Neoplasms, Female in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armand, JP; Barbu, M; Carde, P; Chabot, GG; de Forni, M; Domenge, C; Fontana, X; Gouyette, A; Recondo, G1
Bork, E; Hansen, HH; Vest, S1

Trials

1 trial(s) available for brequinar and Genital Neoplasms, Female

ArticleYear
Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Half-Life; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Thrombocytopenia

1993

Other Studies

1 other study(ies) available for brequinar and Genital Neoplasms, Female

ArticleYear
A phase I clinical and pharmacokinetic study of Brequinar sodium, DUP 785 (NSC 368390), using a weekly and a biweekly schedule.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Drug Administration Schedule; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Platelet Count; Urologic Neoplasms

1989